Xiaofeng Li
Xiamen, 361005, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Polynorepinephrine nanoagent enables targeted mitochondrial delivery for enhanced tumor therapy through ferroptosis.
Journal: Colloids and surfaces. B, Biointerfaces
Published: July 14, 2025
Retrospective Insights into the Clinicopathological Features and Treatment Outcomes of Thoracic SMARCA4-Deficient Tumors.
Journal: Technology in cancer research & treatment
Published: May 22, 2025
Diagnostic value of exosome-derived lncRNA PITPNA-AS1 in lung cancer.
Journal: Frontiers in immunology
Published: December 04, 2024
PDLIM1, a novel miR-3940-5p target, regulates the malignant progression of diffuse large B-cell lymphoma.
Journal: Cancer biology & therapy
Published: November 20, 2024
Exploring the diagnostic and prognostic significance of circulating tumor cells in stage II-IV colorectal cancer using a nano-based detection method.
Journal: Journal of the Chinese Medical Association : JCMA
Published: August 21, 2024
Mutation of lysine-specific demethylase 5 is associated with enhanced tumor immunity and favorable outcomes in pan-cancer immune checkpoint blockade.
Journal: Molecular cancer
Published: May 20, 2024
SALIRI-based (raltitrexed plus irinotecan) therapy as a second-line treatment for patients with metastatic colorectal cancer (SALLY): A prospective, multicenter, non-interventional, registry study.
Journal: Cancer communications (London, England)
Published: November 17, 2023
Intravenous Patient-Controlled Analgesia Versus Oral Opioid to Maintain Analgesia for Severe Cancer Pain: A Randomized Phase II Trial.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: March 06, 2022
Phase 2 randomized controlled trial of intravenous or intraperitoneal paclitaxel plus mFOLFOX6 vs. mFOLFOX6 as first-line treatment of advanced gastric cancer.
Journal: Frontiers in oncology
Published: January 07, 2022
Preliminary Efficacy and Safety of Camrelizumab in Combination With XELOX Plus Bevacizumab or Regorafenib in Patients With Metastatic Colorectal Cancer: A Retrospective Study.
Journal: Frontiers in oncology
Published: September 12, 2021
Comparing Patient-Controlled Analgesia Versus Non-PCA Hydromorphone Titration for Severe Cancer Pain: A Randomized Phase III Trial.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: October 01, 2020
Last Updated: 09/26/2026